Article Trunk



Posts Tagged ‘biotechnology’

Two former members of Google’s skunkworks division have launched a biomanufacturing company

Biomanufacturing technologies — taking modified versions of existing organisms and bending them to the will of humans — has moved from the world of science fiction to becoming a new reality. Across the startup landscape companies are launching to make synthetic spider silk, or make leather substitutes, or meat substitutes, or novel chemicals and pharmaceuticals. ...

Driving down the cost of preserving genetic material, Acorn Biolabs raises $3.3 million

Acorn Biolabs wants consumers to pay them to store genetic material in a bet that the increasing advances in targeted genetic therapies will yield better healthcare results down the line. The company’s pitch is to “Save young cells today, live a longer, better, tomorrow.” It’s a gamble on the frontiers of healthcare technology that has managed ...

Up to $818 million deal between J&J and Locus Biosciences points to a new path for CRISPR therapies

The up to $818 million deal between Locus Biosciences and Janssen Pharmaceuticals (a division of Johnson & Johnson) that was announced yesterday points toward a new path for CRISPR gene editing technologies and (potentially) the whole field of microbiome-targeted therapies. Based in Research Triangle Park, N.C., Locus is commercializing research initially developed by scientists at ...

Sophia Genetics bags $77M Series E, with 850+ hospitals signed up to its “data-driven medicine”

Another sizeable cash injection for big data biotech: Sophia Genetics has announced a $77M Series E funding round, bringing its total raised to $140M since the business was founded back in 2011. The company, which applies AI to DNA sequencing to enable what it dubs “data-driven medicine”, last closed a $30M Series D in fall 2017. ...

Companies tracking mutations in cancer cells can provide a key to unlocking better therapies

Investors and entrepreneurs are beginning to bring new diagnostic tools to market that promise better results for cancer patients through the identification of mutations in cancer cells that can create more targeted therapies. Earlier this month, research using technology developed by the startup Mission Bio helped identify cellular mutations in acute myeloid leukemia cancer cells that could ...

Synthego raises $110 million to make gene editing technologies more accessible

Paul Dabrowski, the chief executive officer of Synthego, which provides genetically engineered cells to scientists and researchers, worries about a future where access to the genetic technologies that will reshape the world are only available to the few who can afford them. To hear him tell it, that’s why Dabrowski began working on Synthego in ...

China is funding the future of American biotech

Silicon Valley is in the midst of a health craze, and it is being driven by “Eastern” medicine. It’s been a record year for US medical investing, but investors in Beijing and Shanghai are now increasingly leading the largest deals for US life science and biotech companies. In fact, Chinese venture firms have invested more this ...

Cotton and jelly sandwich?

The U.S. Department of Agriculture Animal and Plant Health Inspection Service approved the growing of a new kind of cotton plant that's been genetically modified to be edible. The toxic chemical gossypol in the plant usually makes the cotton dangerous for humans to eat. Texas A&M biotechnologist Keerti Rathore and colleagues genetically stopped the production ...

As biological manufacturing moves to the mainstream, Synvitrobio rebrands and raises cash

The pace at which the scientific breakthroughs working to bend the machinery of life to the whims of manufacturing have transformed into real businesses has intensified competition in the biomanufacturing market. That’s just one reason why Synvitrobio is rebranding as it takes on $2.6 million in new financing to pursue opportunities in biopharmaceutical and biochemical manufacturing. ...

23andMe might soon offer a $749 DNA package to give you deeper insights into your DNA

23andMe is testing out a $749 ‘premium’ service for deeper health insights, according to several customers who saw a test page for the new product and posted about it on Reddit. First spotted by CNBC, the company served up a test web page to several customers telling them about a service that would allow them ...